Estamos no ar no ! Saiba mais
92,03 USD
-0,48
0,52%
No fechamento Atualizado 16 de out. 16:00 EDT
Pré-mercado
Após o fechamento do mercado
92,03
0,00
0%
1 dia
-0,52%
5 dias
0,1%
1 mês
-4,14%
3 meses
-6,75%
6 meses
8,87%
No acumulado do ano
1,05%
1 ano
1,09%
5 anos
44,63%
10 anos
150,42%
 

Sobre: HealthEquity Inc provides solutions that allow consumers to make healthcare saving and spending decisions. It provides payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice to grow their tax-advantaged healthcare savings. It manages consumers' tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and administers Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It also provides investment advisory services to customers whose account balances exceed a certain threshold. HealthEquity generates its revenue in the United States.

Funcionários: 2.814

Notícias

Positivo
Neutro
Negativo
Sentimento 3 meses
Positivo 52,6%
Neutro 36,8%
Negativo 10,5%
Positivo
Zacks Investment Research
ontem
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why HealthEquity (HQY) is a Top Growth Stock for the Long-Term
Negativo
Zacks Investment Research
há 9 dias
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's strong HSA growth, AI-driven efficiencies and raised fiscal 2027 outlook support momentum, though cybersecurity risks remain a concern.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Positivo
Seeking Alpha
há 14 dias
HealthEquity: AI Cash Fears Create A 'Buy' Opportunity
HealthEquity stands out as a beneficiary of durable HSA growth and higher-for-longer interest rates, with AI-driven cash-sorting risks seen as overblown. HQY's earnings are poised for material upside as fixed-rate contracts mature, with incremental net interest income tailwinds and strong account growth supporting double-digit EPS growth. Recent financials highlight robust EBITDA margin expansion, conservative leverage near 1x, and active share repurchases, reducing share count by 4% year-over-year.
HealthEquity: AI Cash Fears Create A 'Buy' Opportunity
Neutro
GlobeNewsWire
há 16 dias
HealthEquity Appoints Moody's CFO Noémie Heuland to Board of Directors
DRAPER, Utah, Sept. 30, 2026 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), the largest independent health savings account (HSA) custodian by account volume and a leader in consumer-directed benefits (CDB), today announced that Noémie Heuland, Chief Financial Officer of Moody's Corporation (NYSE: MCO), has been elected to its board of directors (the “Board”) effective Sept.
HealthEquity Appoints Moody's CFO Noémie Heuland to Board of Directors
Positivo
Zacks Investment Research
há 22 dias
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Negativo
Zacks Investment Research
mês passado
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
HQY's growth is driven by rising HSA assets and AI-led efficiencies, while cybersecurity risks remain a key concern.
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
Neutro
Zacks Investment Research
mês passado
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
HealthEquity's 15.7% three-month rally is backed by rising HSA scale, stronger margins and higher guidance, though key risks remain.
HQY Up 15.7% in 3 Months as HSA Growth Builds: Can the Rally Continue?
Positivo
Zacks Investment Research
mês passado
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why HealthEquity (HQY) is a Strong Growth Stock
Neutro
The Motley Fool
mês passado
Why HealthEquity Stock Sank This Week
HealthEquity posted significant sales and earnings beats with its fiscal Q2 report. The company issued a small increase for its full-year guidance, but management kept its forecast for adjusted earnings per share the same.
Why HealthEquity Stock Sank This Week
Neutro
Seeking Alpha
mês passado
HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript
HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript
HealthEquity, Inc. (HQY) Q2 2027 Earnings Call Transcript
Gráficos de preços implementados com Lightweight Charts™